Successful Treatment of Pediatric Refractory Burkitt Lymphoma PTLD after Liver Transplantation using Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy

Successful Treatment of Pediatric Refractory Burkitt Lymphoma PTLD after Liver Transplantation using Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy

In the immunocompromised setting, recipients of solid-organ or hematopoietic stem-cell transplants carry an increased risk of post-transplant lymphoproliferative disorder (PTLD). Burkitt lymphoma (BL) PTLD is a rare form of monomorphic B-cell PTLD, which lacks a standard best treatment. Here, we rep...

Full description

Bibliographic Details
Main Authors: Tianyi Wang, Mingxuan Feng, Chengjuan Luo, Xinyu Wan, Ci Pan, Jingyan Tang, Feng Xue, Minzhi Yin, Dongqing Lu, Qiang Xia, Benshang Li, Jing Chen
Format: Article
Language:English
Published: SAGE Publishing 2021-02-01
Series:Cell Transplantation
Online Access:https://doi.org/10.1177/0963689721996649

Internet

https://doi.org/10.1177/0963689721996649

Similar Items